Logo image of CORZ

CORE SCIENTIFIC INC (CORZ) Stock Fundamental Analysis

NASDAQ:CORZ - Nasdaq - US21874A1060 - Common Stock - Currency: USD

11.89  -0.25 (-2.06%)

After market: 11.95 +0.06 (+0.5%)

Fundamental Rating

3

CORZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. While CORZ seems to be doing ok healthwise, there are quite some concerns on its profitability. CORZ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CORZ has reported negative net income.
CORZ had a negative operating cash flow in the past year.
In the past 5 years CORZ reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CORZ reported negative operating cash flow in multiple years.
CORZ Yearly Net Income VS EBIT VS OCF VS FCFCORZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

With a Return On Assets value of -54.13%, CORZ is not doing good in the industry: 84.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -54.13%
ROE N/A
ROIC N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CORZ Yearly ROA, ROE, ROICCORZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

With a Gross Margin value of 12.57%, CORZ is not doing good in the industry: 84.86% of the companies in the same industry are doing better.
CORZ's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CORZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
CORZ Yearly Profit, Operating, Gross MarginsCORZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

5

2. Health

2.1 Basic Checks

CORZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CORZ has less shares outstanding
The number of shares outstanding for CORZ has been reduced compared to 5 years ago.
CORZ has a better debt/assets ratio than last year.
CORZ Yearly Shares OutstandingCORZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CORZ Yearly Total Debt VS Total AssetsCORZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CORZ has an Altman-Z score of -1.04. This is a bad value and indicates that CORZ is not financially healthy and even has some risk of bankruptcy.
CORZ has a worse Altman-Z score (-1.04) than 73.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.04
ROIC/WACCN/A
WACC7.89%
CORZ Yearly LT Debt VS Equity VS FCFCORZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

CORZ has a Current Ratio of 4.26. This indicates that CORZ is financially healthy and has no problem in meeting its short term obligations.
CORZ's Current ratio of 4.26 is amongst the best of the industry. CORZ outperforms 84.15% of its industry peers.
A Quick Ratio of 4.26 indicates that CORZ has no problem at all paying its short term obligations.
CORZ's Quick ratio of 4.26 is amongst the best of the industry. CORZ outperforms 84.51% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.26
CORZ Yearly Current Assets VS Current LiabilitesCORZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

CORZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2858.82%.
The Revenue for CORZ has decreased by -26.76% in the past year. This is quite bad
Measured over the past years, CORZ shows a very strong growth in Revenue. The Revenue has been growing by 53.71% on average per year.
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
Revenue 1Y (TTM)-26.76%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-55.64%

3.2 Future

Based on estimates for the next years, CORZ will show a very strong growth in Earnings Per Share. The EPS will grow by 27.43% on average per year.
The Revenue is expected to grow by 32.74% on average over the next years. This is a very strong growth
EPS Next Y96.15%
EPS Next 2Y43.19%
EPS Next 3Y27.43%
EPS Next 5YN/A
Revenue Next Year-19.55%
Revenue Next 2Y29%
Revenue Next 3Y33.34%
Revenue Next 5Y32.74%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CORZ Yearly Revenue VS EstimatesCORZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
CORZ Yearly EPS VS EstimatesCORZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

2

4. Valuation

4.1 Price/Earnings Ratio

CORZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CORZ is valuated quite expensively with a Price/Forward Earnings ratio of 38.60.
The rest of the industry has a similar Price/Forward Earnings ratio as CORZ.
The average S&P500 Price/Forward Earnings ratio is at 22.13. CORZ is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 38.6
CORZ Price Earnings VS Forward Price EarningsCORZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CORZ Per share dataCORZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

CORZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CORZ's earnings are expected to grow with 27.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.19%
EPS Next 3Y27.43%

0

5. Dividend

5.1 Amount

CORZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORE SCIENTIFIC INC

NASDAQ:CORZ (6/13/2025, 8:00:01 PM)

After market: 11.95 +0.06 (+0.5%)

11.89

-0.25 (-2.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners81.81%
Inst Owner Change-3.85%
Ins Owners3.22%
Ins Owner Change2.04%
Market Cap3.54B
Analysts85
Price Target18.33 (54.16%)
Short Float %16.73%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)326.79%
Min EPS beat(2)-602.54%
Max EPS beat(2)1256.12%
EPS beat(4)1
Avg EPS beat(4)-3604.56%
Min EPS beat(4)-13917.4%
Max EPS beat(4)1256.12%
EPS beat(8)3
Avg EPS beat(8)-1895.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.56%
Min Revenue beat(2)-12.25%
Max Revenue beat(2)-6.86%
Revenue beat(4)1
Avg Revenue beat(4)-5.06%
Min Revenue beat(4)-12.25%
Max Revenue beat(4)7.59%
Revenue beat(8)3
Avg Revenue beat(8)-5.97%
Revenue beat(12)4
Avg Revenue beat(12)-5.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.86%
PT rev (3m)-7.84%
EPS NQ rev (1m)-26.43%
EPS NQ rev (3m)-394.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-230.27%
Revenue NQ rev (1m)-2.39%
Revenue NQ rev (3m)-38.39%
Revenue NY rev (1m)-2.2%
Revenue NY rev (3m)-34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 38.6
P/S 8.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.03
EYN/A
EPS(NY)0.31
Fwd EY2.59%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS1.38
BVpS-0.61
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.57%
FCFM N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.97%
Cap/Sales 36.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.26
Quick Ratio 4.26
Altman-Z -1.04
F-Score3
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)122.96%
Cap/Depr(5y)360.66%
Cap/Sales(3y)38.66%
Cap/Sales(5y)43.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
EPS Next Y96.15%
EPS Next 2Y43.19%
EPS Next 3Y27.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.76%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-55.64%
Revenue Next Year-19.55%
Revenue Next 2Y29%
Revenue Next 3Y33.34%
Revenue Next 5Y32.74%
EBIT growth 1Y-261.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year695.13%
EBIT Next 3Y204.88%
EBIT Next 5Y188.87%
FCF growth 1Y-62.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.69%
OCF growth 3YN/A
OCF growth 5YN/A